The estimated Net Worth of Erin Powers Brennan is at least $91.6 Thousand dollars as of 27 February 2020. Ms. Brennan owns over 1,668 units of Covetrus stock worth over $91,621 and over the last 5 years she sold CVET stock worth over $0. In addition, she makes $0 as Senior Vice President, General Counsel, and Secretary at Covetrus.
Erin has made over 2 trades of the Covetrus stock since 2019, according to the Form 4 filled with the SEC. Most recently she exercised 1,668 units of CVET stock worth $35,011 on 27 February 2020.
The largest trade she's ever made was buying 1,684 units of Covetrus stock on 21 August 2019 worth over $25,092. On average, Erin trades about 479 units every 27 days since 2019. As of 27 February 2020 she still owns at least 4,365 units of Covetrus stock.
You can see the complete history of Ms. Brennan stock trades at the bottom of the page.
Erin Powers Brennan is Senior Vice President, General Counsel, Secretary of the Company. From April 2018 until such appointment, Ms. Brennan served as general counsel of Vets First Choice. Prior to joining Vets First Choice, Ms. Brennan was a partner at Morgan, Lewis & Bockius LLP, a law firm, where she worked from September 2013 to April 2018. Ms. Brennan holds a J.D. from Boston College Law School, an M.A. in Law and Diplomacy from the Tufts University Fletcher School of Law and Diplomacy and a B.A. in Government and Latin American Studies from Scripps College.
Erin Brennan is 49, she's been the Senior Vice President, General Counsel, and Secretary of Covetrus since 2019. There are 20 older and 6 younger executives at Covetrus. The oldest executive at Covetrus, Inc. is Philip Laskawy, 78, who is the Independent Chairman of the Board.
Over the last 5 years, insiders at Covetrus have traded over $10,243,394 worth of Covetrus stock and bought 11,744 units worth $216,180 . The most active insiders traders include Steven Paladino, Benjamin Wolin, and Philip A Laskawy. On average, Covetrus executives and independent directors trade stock every 10 days with the average trade being worth of $268,798. The most recent stock trade was executed by Rebecca Ann Kidd on 1 October 2022, trading 1,232 units of CVET stock currently worth $25,860.
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine.
Covetrus executives and other stock owners filed with the SEC include: